Merck & Co Inc [MRK] stock is trading at $98.34, down -1.72%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MRK shares have lost -1.41% over the last week, with a monthly amount glided 1.84%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, HSBC Securities upgraded its rating to Buy on December 04, 2024, and kept the price target unchanged to $130. On November 15, 2024, Wolfe Research initiated with a Peer Perform rating. Daiwa Securities downgraded its rating to a Neutral. Bernstein initiated its recommendation with a Mkt Perform and recommended $115 as its price target on October 17, 2024. Societe Generale downgraded its rating to Sell for this stock on March 11, 2024, but kept the price target unchanged to $104. In a note dated January 04, 2024, TD Cowen upgraded an Outperform rating on this stock and boosted its target price from $125 to $135.
Merck & Co Inc [MRK] stock has fluctuated between $94.48 and $134.63 over the past year. Currently, Wall Street analysts expect the stock to reach $135.83 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $98.34 at the most recent close of the market. An investor can expect a potential return of 38.12% based on the average MRK price forecast.
Analyzing the MRK fundamentals
Merck & Co Inc [NYSE:MRK] reported sales of 62.89B for the trailing twelve months, which represents a growth of 4.42%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.29 and Total Capital is 0.17. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 97.24 points at the first support level, and at 96.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 100.47, and for the 2nd resistance point, it is at 102.60.
Ratios To Look Out For
For context, Merck & Co Inc’s Current Ratio is 1.36. Further, the Quick Ratio stands at 1.15, while the Cash Ratio is 0.49. Considering the valuation of this stock, the price to sales ratio is 3.96, the price to book ratio is 5.60 and price to earnings (TTM) ratio is 20.60.
Transactions by insiders
Recent insider trading involved Merck & Co., Inc., 10% Owner, that happened on Mar 11 ’24 when 21.4 million shares were purchased. EVP & CFO, Litchfield Caroline completed a deal on Feb 14 ’24 to sell 38291.0 shares. Meanwhile, Chairman, CEO & President Davis Robert M sold 0.15 million shares on Feb 13 ’24.
